Multiple myeloma is a rare and highly heterogeneous hematologic malignancy, and the clinical research certainly plays a fundamental role in the management of patients with this disease. To deal with such a complex scenario, in 2005, a group of European hematologists pulled together to increase their understanding of multiple myeloma and to produce effective research projects and clinical trials. These efforts resulted in the creation of the European Myeloma Network (EMN), a non profit organization. EMN is a HARMONY Partner. An important Multiple Myeloma project is being coordinated by the EMN within HARMONY, and it involves many European sites.
Presentation of Mattia D'Agostino, University of Turin, HARMONY Research Multiple Myeloma Project Lead. The title of the HARMONY Research MM project is: “Second revision of the international staging system (R2-ISS) for Multiple Myeloma”, which is being conducted through the HARMONY BigData Platform.
#bigdataforbloodcancer: Accelerating Better and Faster Treatment for Patients with Hematologic Malignancies.
The HARMONY Alliance (HARMONY and HARMONY PLUS) is a public-private European Network of Excellence for Big Data in Hematology. Our mission is to unlock and spread valuable knowledge on hematologic malignancies (blood cancers) among a large number of stakeholders, with the goal to harness and mine Big Data to speed up the development of improved treatments for patients and more effective treatment strategies.
Receive the latest news. Click here to subscribe!